ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIHCU(GBX) LSE
ETF TickerIUHC(USD) LSE
ETF TickerQDVG(EUR) F
ETF TickerIHCU.LS(GBX) CXE
ETF TickerIUHC.LS(USD) CXE
ETF TickerIUHCz(USD) CXE
ETF TickerQDVG.DE(EUR) CXE
ETF TickerIHCU.L(GBP) LSE
ETF TickerIUHC.L(GBP) LSE

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-12-03 (Wednesday)81,820USD 8,304,730INCY holding increased by 4909USD 8,304,7300USD 4,909 USD 101.5 USD 101.44
2025-12-02 (Tuesday)81,820INCY holding decreased by -1012USD 8,299,821INCY holding decreased by -152356USD 8,299,821-1,012USD -152,356 USD 101.44 USD 102.04
2025-12-01 (Monday)82,832INCY holding increased by 30USD 8,452,177INCY holding decreased by -197320USD 8,452,17730USD -197,320 USD 102.04 USD 104.46
2025-11-28 (Friday)82,802INCY holding increased by 546USD 8,649,497INCY holding decreased by -40849USD 8,649,497546USD -40,849 USD 104.46 USD 105.65
2025-11-27 (Thursday)82,256USD 8,690,346USD 8,690,3460USD 0 USD 105.65 USD 105.65
2025-11-26 (Wednesday)82,256INCY holding decreased by -184USD 8,690,346INCY holding decreased by -11196USD 8,690,346-184USD -11,196 USD 105.65 USD 105.55
2025-11-25 (Tuesday)82,440INCY holding increased by 184USD 8,701,542INCY holding decreased by -37335USD 8,701,542184USD -37,335 USD 105.55 USD 106.24
2025-11-24 (Monday)82,256INCY holding increased by 455USD 8,738,877INCY holding increased by 390267USD 8,738,877455USD 390,267 USD 106.24 USD 102.06
2025-11-21 (Friday)81,801USD 8,348,610INCY holding increased by 24540USD 8,348,6100USD 24,540 USD 102.06 USD 101.76
2025-11-20 (Thursday)81,801INCY holding increased by 91USD 8,324,070INCY holding increased by 45213USD 8,324,07091USD 45,213 USD 101.76 USD 101.32
2025-11-19 (Wednesday)81,710USD 8,278,857INCY holding decreased by -209995USD 8,278,8570USD -209,995 USD 101.32 USD 103.89
2025-11-18 (Tuesday)81,710USD 8,488,852INCY holding decreased by -22879USD 8,488,8520USD -22,879 USD 103.89 USD 104.17
2025-11-17 (Monday)81,710USD 8,511,731INCY holding increased by 1634USD 8,511,7310USD 1,634 USD 104.17 USD 104.15
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00B43HR379

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02SELL-1,012103.540100.550 100.849USD -102,059 74.33 Loss of -26,836 on sale
2025-12-01BUY30103.890101.470 101.712USD 3,051 74.21
2025-11-28BUY546106.990103.850 104.164USD 56,874 74.07
2025-11-26SELL-184107.000105.085 105.276USD -19,371 73.79 Loss of -5,793 on sale
2025-11-26SELL-184107.000105.085 105.276USD -19,371 73.79 Loss of -5,793 on sale
2025-11-25BUY184107.605105.160 105.405USD 19,394 73.65
2025-11-24BUY455106.670102.503 102.920USD 46,828 73.50
2025-11-20BUY91103.225101.080 101.295USD 9,218 73.24
2025-11-12SELL-364109.275106.810 107.056USD -38,969 72.36 Loss of -12,630 on sale
2025-11-10BUY910108.810104.070 104.544USD 95,135 72.03
2025-11-06BUY91106.430103.075 103.410USD 9,410 71.71
2025-11-05SELL-91106.470101.500 101.997USD -9,282 71.55 Loss of -2,771 on sale
2025-11-04BUY91103.860100.020 100.404USD 9,137 71.39
2025-10-31BUY46095.10092.058 92.362USD 42,486 71.14
2025-10-30SELL-55294.62091.190 91.533USD -50,526 71.03 Loss of -11,315 on sale
2025-10-29SELL-18490.18094.420 93.996USD -17,295 70.94 Loss of -4,242 on sale
2025-10-28BUY17591.65093.980 93.747USD 16,406 70.84
2025-10-27SELL-18493.08093.170 93.161USD -17,142 70.73 Loss of -4,128 on sale
2025-10-22SELL-9288.06088.210 88.195USD -8,114 70.44 Loss of -1,633 on sale
2025-10-17SELL-36887.57088.540 88.443USD -32,547 70.19 Loss of -6,718 on sale
2025-10-16BUY46087.31092.860 92.305USD 42,460 70.10
2025-10-15BUY64488.15088.490 88.456USD 56,966 70.00
2025-10-14BUY9285.96086.160 86.140USD 7,925 69.92
2025-10-06BUY46087.23088.300 88.193USD 40,569 69.74
2025-10-03BUY18286.85086.980 86.967USD 15,828 69.65
2025-10-02BUY9186.28088.660 88.422USD 8,046 69.56
2025-10-01BUY53086.70087.240 87.186USD 46,209 69.47
2025-09-24BUY2,23884.16084.820 84.754USD 189,679 69.09
2025-09-18BUY8986.00086.070 86.063USD 7,660 68.99
2025-09-11BUY8986.17087.100 87.007USD 7,744 68.72
2025-09-10BUY8986.25086.940 86.871USD 7,732 68.62
2025-08-20BUY17686.20086.370 86.353USD 15,198 68.12
2025-08-19BUY8885.46085.690 85.667USD 7,539 68.02
2025-07-17SELL-8968.94069.650 69.579USD -6,193 68.01 Loss of -139 on sale
2025-07-15SELL-35668.25070.150 69.960USD -24,906 68.00 Loss of -697 on sale
2025-07-14SELL-89069.98070.040 70.034USD -62,330 67.99 Loss of -1,818 on sale
2025-07-09SELL-8968.72069.300 69.242USD -6,163 67.97 Loss of -113 on sale
2025-07-07SELL-17867.27068.250 68.152USD -12,131 67.97 Loss of -32 on sale
2025-07-02BUY8968.17069.100 69.007USD 6,142 67.97
2025-06-24SELL-1,51369.01069.540 69.487USD -105,134 67.94 Loss of -2,340 on sale
2025-06-23BUY8967.26068.780 68.628USD 6,108 67.94
2025-06-20SELL-17868.46069.190 69.117USD -12,303 67.94 Loss of -209 on sale
2025-06-18SELL-8968.27069.470 69.350USD -6,172 67.94 Loss of -126 on sale
2025-06-17BUY1,06868.81070.890 70.682USD 75,488 67.93
2025-06-13SELL-17867.75068.960 68.839USD -12,253 67.91 Loss of -165 on sale
2025-06-11SELL-8968.85070.360 70.209USD -6,249 67.89 Loss of -206 on sale
2025-06-10SELL-17870.07070.980 70.889USD -12,618 67.88 Loss of -536 on sale
2025-06-09SELL-26769.89069.960 69.953USD -18,677 67.86 Loss of -558 on sale
2025-05-21SELL-8964.78065.460 65.392USD -5,820 68.08 Profit of 239 on sale
2025-05-20SELL-17865.30066.110 66.029USD -11,753 68.10 Profit of 369 on sale
2025-05-15SELL-26762.76062.990 62.967USD -16,812 68.22 Profit of 1,402 on sale
2025-05-14SELL-26761.16062.500 62.366USD -16,652 68.28 Profit of 1,578 on sale
2025-05-13BUY8960.81061.150 61.116USD 5,439 68.34
2025-05-09SELL-8958.98060.480 60.330USD -5,369 68.48 Profit of 725 on sale
2025-05-08BUY17859.73059.990 59.964USD 10,674 68.55
2025-05-01BUY17862.03062.640 62.579USD 11,139 68.88
2025-04-24SELL-8958.97059.050 59.042USD -5,255 69.28 Profit of 912 on sale
2025-04-23BUY26758.00059.010 58.909USD 15,729 69.39
2025-04-15SELL-8958.46059.950 59.801USD -5,322 70.08 Profit of 915 on sale
2025-04-10SELL-17455.17058.330 58.014USD -10,094 70.48 Profit of 2,168 on sale
2025-04-08SELL-8756.97061.470 61.020USD -5,309 70.74 Profit of 845 on sale
2025-04-07SELL-8760.29061.060 60.983USD -5,306 70.85 Profit of 858 on sale
2025-04-04SELL-17460.58063.570 63.271USD -11,009 70.96 Profit of 1,337 on sale
2025-04-02BUY8762.33062.530 62.510USD 5,438 71.05
2025-04-01BUY78360.91062.000 61.891USD 48,461 71.16
2025-03-31SELL-52260.55060.810 60.784USD -31,729 71.28 Profit of 5,477 on sale
2025-03-28BUY8760.60060.970 60.933USD 5,301 71.39
2025-03-26SELL-5761.26062.880 62.718USD -3,575 71.63 Profit of 508 on sale
2025-03-21BUY60961.92062.330 62.289USD 37,934 71.96
2025-03-20BUY35660.58061.750 61.633USD 21,941 72.10
2025-03-17SELL-8862.01063.450 63.306USD -5,571 72.52 Profit of 811 on sale
2025-03-12BUY2,43567.73068.230 68.180USD 166,018 72.70
2025-03-07BUY8670.79072.810 72.608USD 6,244 72.81
2025-02-28SELL-25873.50073.630 73.617USD -18,993 72.92 Loss of -180 on sale
2025-02-25BUY86074.40076.240 76.056USD 65,408 72.87
2025-02-20BUY60271.38071.520 71.506USD 43,047 72.89
2025-02-19BUY25870.16071.430 71.303USD 18,396 72.93
2025-02-18BUY17271.27071.680 71.639USD 12,322 72.96
2025-02-13BUY43070.01072.690 72.422USD 31,141 73.09
2025-02-04BUY34474.12074.920 74.840USD 25,745 73.27
2025-01-31BUY8674.16075.180 75.078USD 6,457 73.25
2025-01-29BUY8673.72074.110 74.071USD 6,370 73.23
2025-01-27BUY17272.64073.430 73.351USD 12,616 73.24
2025-01-24BUY8672.59073.680 73.571USD 6,327 73.26
2025-01-22BUY34472.41073.550 73.436USD 25,262 73.29
2024-12-10SELL-8572.48073.100 73.038USD -6,208 73.60 Profit of 48 on sale
2024-12-09SELL-2,21072.11075.980 75.593USD -167,061 73.65 Loss of -4,291 on sale
2024-12-03SELL-1,02072.03072.960 72.867USD -74,324 73.55 Profit of 695 on sale
2024-12-02SELL-42573.24074.700 74.554USD -31,685 73.56 Loss of -422 on sale
2024-11-29SELL-8674.59076.080 75.931USD -6,530 73.52 Loss of -207 on sale
2024-11-22SELL-85071.72072.000 71.972USD -61,176 73.36 Profit of 1,181 on sale
2024-11-21SELL-42570.39071.400 71.299USD -30,302 73.51 Profit of 940 on sale
2024-11-20BUY68071.05071.680 71.617USD 48,700 73.64
2024-11-18SELL-1,02076.97077.010 77.006USD -78,546 73.62 Loss of -3,449 on sale
2024-11-11BUY76581.53083.540 83.339USD 63,754 72.63
2024-11-08SELL-2,72083.38083.950 83.893USD -228,189 71.87 Loss of -32,712 on sale
2024-11-07SELL-16882.34082.970 82.907USD -13,928 71.06 Loss of -1,990 on sale
2024-11-01SELL-16876.13076.330 76.310USD -12,820 68.19 Loss of -1,365 on sale
2024-10-31SELL-34474.12074.680 74.624USD -25,671 67.44 Loss of -2,470 on sale
2024-10-30BUY8573.93074.600 74.533USD 6,335 66.52
2024-10-29BUY51673.60074.070 74.023USD 38,196 65.34
2024-10-28SELL-25865.69065.880 65.861USD -16,992 65.27 Loss of -153 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy